DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $107,000 | +8.1% | 1,150 | 0.0% | 0.15% | +30.8% |
Q3 2017 | $99,000 | -97.6% | 1,150 | -97.7% | 0.12% | -96.3% |
Q2 2017 | $4,187,000 | -1.3% | 49,611 | 0.0% | 3.20% | +19.6% |
Q1 2017 | $4,243,000 | +0.4% | 49,611 | -8.7% | 2.68% | +4.5% |
Q4 2016 | $4,228,000 | -1.7% | 54,311 | -1.0% | 2.56% | +6.2% |
Q3 2016 | $4,301,000 | -21.4% | 54,861 | +1.2% | 2.41% | -25.9% |
Q2 2016 | $5,475,000 | +6.3% | 54,211 | -0.1% | 3.25% | +18.5% |
Q1 2016 | $5,150,000 | -4.5% | 54,290 | -6.5% | 2.74% | -1.9% |
Q4 2015 | $5,395,000 | +10.5% | 58,090 | +1.4% | 2.80% | +16.3% |
Q3 2015 | $4,882,000 | -3.3% | 57,290 | -2.9% | 2.40% | -0.2% |
Q2 2015 | $5,048,000 | +0.6% | 58,981 | -0.2% | 2.41% | -0.8% |
Q1 2015 | $5,020,000 | -3.1% | 59,125 | -2.2% | 2.43% | -0.0% |
Q4 2014 | $5,179,000 | +10.2% | 60,425 | -2.3% | 2.43% | +13.5% |
Q3 2014 | $4,701,000 | -7.8% | 61,875 | -4.4% | 2.14% | -8.4% |
Q2 2014 | $5,096,000 | -15.1% | 64,725 | -19.1% | 2.34% | -6.5% |
Q1 2014 | $6,000,000 | -31.2% | 80,000 | -29.2% | 2.50% | -30.0% |
Q4 2013 | $8,723,000 | +10.6% | 112,990 | -0.7% | 3.57% | +12.8% |
Q3 2013 | $7,888,000 | +0.4% | 113,790 | -8.3% | 3.16% | -9.8% |
Q2 2013 | $7,855,000 | – | 124,090 | – | 3.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |